Evaluation of [18F]APN-1607 as a PET Biomarker
Completed · Phase 1
Conditions studied: Progressive Supranuclear Palsy, Healthy Volunteers
In brief
The overall goal of this protocol is to evaluate \[18F\]APN-1607 as a PET radiotracer for measuring longitudinal change in tau pathology in participants with PSP.
Key facts
- Study ID
- NCT05005819
- Run by
- Invicro
- People needed
- 12
- Starts
- 2021-05-25
- Expected to finish
- 2024-01-09
- Last updated by the study team
- 2025-02-20
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Invicro — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.